Strategy exploration on strengthening the quality control of stem cell clinical research
10.3760/cma.j.cn113565-20210708-00116
- VernacularTitle:加强干细胞临床研究质量控制的策略探讨
- Author:
Qinghui ZHAO
1
;
Hongming TANG
;
Jialu LI
;
Bin HE
;
Zhongmin LIU
Author Information
1. 同济大学附属东方医院干细胞转化医学产业基地 国家干细胞转化资源库 上海干细胞临床转化研究院 上海市干细胞临床诊疗工程研究中心 200123
- Keywords:
Stem cells;
Clinical research;
Quality control;
Strategy exploration
- From:
Chinese Journal of Medical Science Research Management
2021;34(5):393-396
- CountryChina
- Language:Chinese
-
Abstract:
Objective:To study and analyze the problems and challenges of stem cell clinical research quality control, and explore possible strategies to strengthen the quality control of stem cell clinical research.Methods:Analyze the problems of the stem cell clinical research quality control system, and summarize the factors that affect the quality control of stem cell clinical research.Results:In view of the current status analysis of stem cell clinical research quality control, it is recommended to promote stem cells from following five aspects: strengthening and improving the capacity building of clinical research institutions, establishing stem cell clinical quality control system, strengthening the quality control of stem cell preparations, strengthening the team-building of stem cell clinical research investigators, and establishing a stem cell clinical research data platform.Conclusions:Strengthening the quality control of stem cell clinical research is of great significance for accelerating the clinical research and transformational application of stem cells.
